The Advisory Committee on Immunization Practices, a group of medical and public health experts, voted 14 in favor, with one recusal, paving the way for the organization to officially green light the two-dose vaccine. The Fda approved the use for that age group on Monday.
Previously: The U.S. Food and Drug Administration has expanded the emergency use authorization for the Pfizer-BioNTech Covid-19 vaccine to include children ages 12-to-15 years-old.
That expands the Dec. 11, 2020 use authorization for people 16 and older, and at the same dosage. It means a much bigger swathe of the U.S. population can be vaccinated — including middle schoolers before next September rolls around.
The Fda called the expansion “a significant step in the fight against the Covid-19 pandemic.” The agency is holding a